Media Coverage

Animals: Impact of Dystocia on Milk Production, Somatic Cell Count, Reproduction and Culling in Holstein Dairy Cows

January 19, 2023

Impact Dystocia Holstein Cows


StarFish Medical Bio Services manager, Nick Allan, is a co-author of an original research article titled, Impact of Dystocia on Milk Production, Somatic Cell Count, Reproduction and Culling in Holstein Dairy Cows, published in the January 19, 2023 online edition of Animals.

The objective of this study was to explore the impact that dystocia had on future health and productivity of Holstein dairy cows. A total of 2159 cows across 21 dairy farms in Alberta, Canada were enrolled in this study. Multivariable models were created to explore associations between outcome variables and calving ease score. The study concludes: “It is evident that assistance at calving, particularly a moderate–hard pull, is associated with significant impacts on future milk production and risk of being culled; therefore, efforts should be made to minimize dystocia and prevent these impacts.”

Read the article here.

About The Plant Pathology Journal

Animals is an international and interdisciplinary scholarly open access journal. It publishes original research articles, reviews and communications that offer substantial new insight into any field of study that involves animals, including zoology, ethnozoology, animal science, animal ethics and animal welfare.

Editorial Staff

Prof. Dr. Clive J. C. Phillips
[email protected]


About StarFish Medical

StarFish Medical provides award-winning design, development, commercialization, and flexible manufacturing outsourcing services —100% dedicated to the medical device and life science marketplace. StarFish Medical partners with innovative companies to create and manufacture breakthrough products for a full range of medical specialty areas including: Digital Health, Cardiovascular, Neurology, Urology, Gastroenterology, Otology, Ophthalmology, and In-Vitro Diagnostics.

StarFish Medical’s technical expertise includes electronics, mechanical, software/firmware systems engineering, in addition to industrial design and human factors. Regulatory Affairs (RA) and Quality Assurance (QA) consultants at StarFish Medical provide regulatory assistance for FDA, CE Mark and Health Canada submissions. Services include QA support for setting up QMS for start-up companies with implementation at the client’s site, and assisting with ISO 13485 certification audits.

For media inquiries:

Patrick Dean, Director of Marketing, StarFish Medical, 416.653.9031 [email protected]

Related Link:

« All Media Coverage

Join over 6000 medical device professionals who receive our engineering, regulatory and commercialization insights and tips every month.